Pharmaceutical Executive April 20, 2023
Lisa Henderson

Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.

In two Pharma 2023 sessions, “Digital Health: Does Pharma Know its Role Yet?” and “Power Patient-Reported Outcomes through Digital Health Tools,” the reasons cited for pharma being involved in digital health were threefold: engage patients for the long-term journey with their conditions; keep health systems and physicians connected to their patients; and find patients who need higher efficacy treatments at the right time.

In the second session, Johannes Munding, director, patient experience design and solutions, neuroscience, Novartis, noted of digital health solutions that it’s a good idea to understand how a patient is doing in real-time, in the real-world, and shift away from current...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Digital Health, Pharma, Pharma / Biotech, Technology, Trends
FTC cracks down on drug patents
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
Pfizer beats revenue estimates, raises profit outlook on cost cuts and smaller-than-feared drop in Covid drug sales
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Share This Article